Tech Company Financing Transactions
Navina Funding Round
Navina secured a $55 million Series C funding round on 3/25/2025. Investors included Goldman Sachs, ALIVE Israel HealthTech Fund and Grove Ventures.
Transaction Overview
Company Name
Announced On
3/25/2025
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its expansion across the U.S. healthcare market, enhance its proprietary AI technology, and further drive improvements in patient outcomes by bringing proactive clinical intelligence to every outpatient interaction.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Menachem Begin Rd. 121
Tel Aviv-Yafo, Undisclosed
Israel
Tel Aviv-Yafo, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Navina was born with the vision to create a new world where the time-consuming chaos of patient data is replaced by a logical actionable platform that makes it possible for every physician to assess even the most complex cases in minutes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronen Lavi
Chief Medical Officer
Yair Lewis
Chief Technical Officer
Shay Perera
VP - Bus. Development
Kfir Oved
VP - Marketing
Anne Amario
VP - Operations
Maor Adlin
VP - Product Management
Rotem David
VP - R & D
Keren Hadad
Browse more venture capital transactions:
Prev: 3/25/2025: Hillstar Bio venture capital transaction
Next: 3/26/2025: Soldera venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs